Increased Doses of Adalimumab Are Associated With Clinical Improvement of Hidradenitis Suppurativa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Drugs in Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa
J Drugs Dermatol 2023 Jun 01;22(6)615-618, J Williams, C Guzik, A Wadhera, H NaikFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.